Apyx Medical (APYX) Change in Accured Expenses (2011 - 2026)
Apyx Medical's (APYX) quarterly Change in Accured Expenses came in at $322000.0 in Q2 2026, down 25.64% on a YoY basis from $433000.0 in Q2 2025, and up 118.31% quarter-over-quarter from -$1.8 million in Q1 2026.
Powered by 
Analysis
Apyx Medical (APYX) Change in Accured Expenses (2011 - 2026) Analysis & Trends
Apyx Medical (APYX) has reported Change in Accured Expenses for 16 consecutive years, with $322000.0 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Change in Accured Expenses fell 25.64% year-over-year to $322000.0; the trailing twelve-month figure through Jun 2026 stood at -$805000.0 (up 21.08% YoY), and the FY2025 full-year result was $209000.0, up 109.22% from the prior year.
- Change in Accured Expenses rose to $322000.0 in Q2 2026 per APYX's latest filing, from -$1.8 million in the prior quarter.
- Across five years, Change in Accured Expenses topped out at $1.4 million in Q4 2023 and bottomed at -$1.8 million in Q1 2026.
- Historically, Change in Accured Expenses has averaged -$245944.4 across 5 years, with a median of -$9000.0 in 2024.
- The sharpest annual moves came in 2022 and 2025: Change in Accured Expenses sank 5841.67% in 2022, then soared 546.39% in 2025.
- Over 5 years, Change in Accured Expenses stood at $328000.0 in 2022, then jumped by 335.67% to $1.4 million in 2023, then sank by 93.84% to $88000.0 in 2024, then soared by 528.41% to $553000.0 in 2025, then slumped by 41.77% to $322000.0 in 2026.
- According to Business Quant data, Change in Accured Expenses over the past three periods registered $322000.0, -$1.8 million, and $553000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.77 Bn | 175.17 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 127.65 Bn | 122.43 Bn | 1.96 Bn | 55.00 Mn |
| 3 | Medtronic | 117.15 Bn | 108.33 Bn | 6.34 Bn | -531.00 Mn |
| 4 | Stryker | 104.21 Bn | 100.73 Bn | 4.50 Bn | 298.00 Mn |
| 5 | Boston Scientific | 63.46 Bn | 62.92 Bn | 3.85 Bn | 234.00 Mn |
| 6 | Edwards Lifesciences | 49.73 Bn | 45.48 Bn | 1.35 Bn | 123.70 Mn |
| 7 | Alcon | 33.01 Bn | 31.56 Bn | 1.68 Bn | -74.00 Mn |
| 8 | Dexcom | 32.17 Bn | 30.22 Bn | 830.00 Mn | 112.90 Mn |
| 9 | Steris | 20.72 Bn | 20.24 Bn | 684.20 Mn | 4.80 Mn |
| 10 | Apyx Medical | 130.67 Mn | 103.06 Mn | 8.87 Mn | 322,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 322,000.00 |
| Mar 31, 2026 | -1.76 Mn |
| Dec 31, 2025 | 553,000.00 |
| Sep 30, 2025 | 79,000.00 |
| Jun 30, 2025 | 433,000.00 |
| Mar 31, 2025 | -856,000.00 |
| Dec 31, 2024 | 88,000.00 |
| Sep 30, 2024 | -685,000.00 |
| Jun 30, 2024 | -97,000.00 |
| Mar 31, 2024 | -1.57 Mn |
| Dec 31, 2023 | 1.43 Mn |
| Sep 30, 2023 | 807,000.00 |
| Jun 30, 2023 | -525,000.00 |
| Mar 31, 2023 | -1.44 Mn |
| Dec 31, 2022 | 328,000.00 |
| Sep 30, 2022 | 275,000.00 |
| Jun 30, 2022 | -433,000.00 |
| Mar 31, 2022 | -1.38 Mn |
| Dec 31, 2021 | 1.79 Mn |
| Sep 30, 2021 | 1.05 Mn |